Global Drugs for Herpes Labialis (Oral Herpes) Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
According to APO Research, The global Drugs for Herpes Labialis (Oral Herpes) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Herpes Labialis (Oral Herpes) include GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon and Luoxin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Herpes Labialis (Oral Herpes), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Herpes Labialis (Oral Herpes).
The Drugs for Herpes Labialis (Oral Herpes) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Herpes Labialis (Oral Herpes) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Herpes Labialis (Oral Herpes) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Herpes Labialis (Oral Herpes) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Herpes Labialis (Oral Herpes).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drugs for Herpes Labialis (Oral Herpes) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
According to APO Research, The global Drugs for Herpes Labialis (Oral Herpes) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Herpes Labialis (Oral Herpes) include GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon and Luoxin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs for Herpes Labialis (Oral Herpes), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Herpes Labialis (Oral Herpes).
The Drugs for Herpes Labialis (Oral Herpes) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Herpes Labialis (Oral Herpes) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK
- Novartis
- Teva
- Mylan
- Cadila
- Apotex
- Daewoong Pharmaceutical
- Livzon
- Luoxin
- Med shine
- Bayer (Campho Phenique)
- Blistex
- Kelun
- Hikma
- Haiwang
- Carmex
- Cipher
- Aciclovir
- Valacyclovir
- Famciclovir
- Docosanol
- Other
- External Use
- Oral
- Injection
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Herpes Labialis (Oral Herpes) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Herpes Labialis (Oral Herpes) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Herpes Labialis (Oral Herpes).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drugs for Herpes Labialis (Oral Herpes) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2030)
1.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2024)
1.4.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2025-2030)
1.5 Key Regions Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030)
1.5.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
2 DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET BY TYPE
2.1 Type Introduction
2.1.1 Aciclovir
2.1.2 Valacyclovir
2.1.3 Famciclovir
2.1.4 Docosanol
2.1.5 Other
2.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Type (2019-2030)
2.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size Review by Type (2019-2024)
2.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Type (2025-2030)
2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions
2.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
3 DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 External Use
3.1.2 Oral
3.1.3 Injection
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
3.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Application (2019-2030)
3.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size Review by Application (2019-2024)
3.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Application (2025-2030)
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions
3.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends
4.2 Drugs for Herpes Labialis (Oral Herpes) Industry Drivers
4.3 Drugs for Herpes Labialis (Oral Herpes) Industry Opportunities and Challenges
4.4 Drugs for Herpes Labialis (Oral Herpes) Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Drugs for Herpes Labialis (Oral Herpes) Revenue (2019-2024)
5.2 Global Drugs for Herpes Labialis (Oral Herpes) Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Drugs for Herpes Labialis (Oral Herpes) Key Company Headquarters & Area Served
5.4 Global Drugs for Herpes Labialis (Oral Herpes) Company, Product Type & Application
5.5 Global Drugs for Herpes Labialis (Oral Herpes) Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Drugs for Herpes Labialis (Oral Herpes) Market CR5 and HHI
5.6.2 Global Top 5 and 10 Drugs for Herpes Labialis (Oral Herpes) Players Market Share by Revenue in 2023
5.6.3 2023 Drugs for Herpes Labialis (Oral Herpes) Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 GSK Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.1.5 GSK Recent Developments
6.2 Novartis
6.2.1 Novartis Comapny Information
6.2.2 Novartis Business Overview
6.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Novartis Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.2.5 Novartis Recent Developments
6.3 Teva
6.3.1 Teva Comapny Information
6.3.2 Teva Business Overview
6.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Teva Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.3.5 Teva Recent Developments
6.4 Mylan
6.4.1 Mylan Comapny Information
6.4.2 Mylan Business Overview
6.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Mylan Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.4.5 Mylan Recent Developments
6.5 Cadila
6.5.1 Cadila Comapny Information
6.5.2 Cadila Business Overview
6.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Cadila Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.5.5 Cadila Recent Developments
6.6 Apotex
6.6.1 Apotex Comapny Information
6.6.2 Apotex Business Overview
6.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Apotex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.6.5 Apotex Recent Developments
6.7 Daewoong Pharmaceutical
6.7.1 Daewoong Pharmaceutical Comapny Information
6.7.2 Daewoong Pharmaceutical Business Overview
6.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.7.5 Daewoong Pharmaceutical Recent Developments
6.8 Livzon
6.8.1 Livzon Comapny Information
6.8.2 Livzon Business Overview
6.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Livzon Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.8.5 Livzon Recent Developments
6.9 Luoxin
6.9.1 Luoxin Comapny Information
6.9.2 Luoxin Business Overview
6.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.9.5 Luoxin Recent Developments
6.10 Med shine
6.10.1 Med shine Comapny Information
6.10.2 Med shine Business Overview
6.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Med shine Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.10.5 Med shine Recent Developments
6.11 Bayer (Campho Phenique)
6.11.1 Bayer (Campho Phenique) Comapny Information
6.11.2 Bayer (Campho Phenique) Business Overview
6.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.11.5 Bayer (Campho Phenique) Recent Developments
6.12 Blistex
6.12.1 Blistex Comapny Information
6.12.2 Blistex Business Overview
6.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Blistex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.12.5 Blistex Recent Developments
6.13 Kelun
6.13.1 Kelun Comapny Information
6.13.2 Kelun Business Overview
6.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Kelun Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.13.5 Kelun Recent Developments
6.14 Hikma
6.14.1 Hikma Comapny Information
6.14.2 Hikma Business Overview
6.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Hikma Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.14.5 Hikma Recent Developments
6.15 Haiwang
6.15.1 Haiwang Comapny Information
6.15.2 Haiwang Business Overview
6.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.15.5 Haiwang Recent Developments
6.16 Carmex
6.16.1 Carmex Comapny Information
6.16.2 Carmex Business Overview
6.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Carmex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.16.5 Carmex Recent Developments
6.17 Cipher
6.17.1 Cipher Comapny Information
6.17.2 Cipher Business Overview
6.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 Cipher Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.17.5 Cipher Recent Developments
7 NORTH AMERICA
7.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
7.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
8.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
9.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
10.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
11.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2030)
1.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2024)
1.4.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2025-2030)
1.5 Key Regions Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030)
1.5.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
2 DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET BY TYPE
2.1 Type Introduction
2.1.1 Aciclovir
2.1.2 Valacyclovir
2.1.3 Famciclovir
2.1.4 Docosanol
2.1.5 Other
2.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Type (2019-2030)
2.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size Review by Type (2019-2024)
2.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Type (2025-2030)
2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions
2.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
3 DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 External Use
3.1.2 Oral
3.1.3 Injection
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
3.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Application (2019-2030)
3.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size Review by Application (2019-2024)
3.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Application (2025-2030)
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions
3.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends
4.2 Drugs for Herpes Labialis (Oral Herpes) Industry Drivers
4.3 Drugs for Herpes Labialis (Oral Herpes) Industry Opportunities and Challenges
4.4 Drugs for Herpes Labialis (Oral Herpes) Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Drugs for Herpes Labialis (Oral Herpes) Revenue (2019-2024)
5.2 Global Drugs for Herpes Labialis (Oral Herpes) Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Drugs for Herpes Labialis (Oral Herpes) Key Company Headquarters & Area Served
5.4 Global Drugs for Herpes Labialis (Oral Herpes) Company, Product Type & Application
5.5 Global Drugs for Herpes Labialis (Oral Herpes) Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Drugs for Herpes Labialis (Oral Herpes) Market CR5 and HHI
5.6.2 Global Top 5 and 10 Drugs for Herpes Labialis (Oral Herpes) Players Market Share by Revenue in 2023
5.6.3 2023 Drugs for Herpes Labialis (Oral Herpes) Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 GSK Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.1.5 GSK Recent Developments
6.2 Novartis
6.2.1 Novartis Comapny Information
6.2.2 Novartis Business Overview
6.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Novartis Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.2.5 Novartis Recent Developments
6.3 Teva
6.3.1 Teva Comapny Information
6.3.2 Teva Business Overview
6.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Teva Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.3.5 Teva Recent Developments
6.4 Mylan
6.4.1 Mylan Comapny Information
6.4.2 Mylan Business Overview
6.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Mylan Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.4.5 Mylan Recent Developments
6.5 Cadila
6.5.1 Cadila Comapny Information
6.5.2 Cadila Business Overview
6.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Cadila Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.5.5 Cadila Recent Developments
6.6 Apotex
6.6.1 Apotex Comapny Information
6.6.2 Apotex Business Overview
6.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Apotex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.6.5 Apotex Recent Developments
6.7 Daewoong Pharmaceutical
6.7.1 Daewoong Pharmaceutical Comapny Information
6.7.2 Daewoong Pharmaceutical Business Overview
6.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.7.5 Daewoong Pharmaceutical Recent Developments
6.8 Livzon
6.8.1 Livzon Comapny Information
6.8.2 Livzon Business Overview
6.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Livzon Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.8.5 Livzon Recent Developments
6.9 Luoxin
6.9.1 Luoxin Comapny Information
6.9.2 Luoxin Business Overview
6.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.9.5 Luoxin Recent Developments
6.10 Med shine
6.10.1 Med shine Comapny Information
6.10.2 Med shine Business Overview
6.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Med shine Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.10.5 Med shine Recent Developments
6.11 Bayer (Campho Phenique)
6.11.1 Bayer (Campho Phenique) Comapny Information
6.11.2 Bayer (Campho Phenique) Business Overview
6.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.11.5 Bayer (Campho Phenique) Recent Developments
6.12 Blistex
6.12.1 Blistex Comapny Information
6.12.2 Blistex Business Overview
6.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Blistex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.12.5 Blistex Recent Developments
6.13 Kelun
6.13.1 Kelun Comapny Information
6.13.2 Kelun Business Overview
6.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Kelun Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.13.5 Kelun Recent Developments
6.14 Hikma
6.14.1 Hikma Comapny Information
6.14.2 Hikma Business Overview
6.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Hikma Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.14.5 Hikma Recent Developments
6.15 Haiwang
6.15.1 Haiwang Comapny Information
6.15.2 Haiwang Business Overview
6.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.15.5 Haiwang Recent Developments
6.16 Carmex
6.16.1 Carmex Comapny Information
6.16.2 Carmex Business Overview
6.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Carmex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.16.5 Carmex Recent Developments
6.17 Cipher
6.17.1 Cipher Comapny Information
6.17.2 Cipher Business Overview
6.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 Cipher Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.17.5 Cipher Recent Developments
7 NORTH AMERICA
7.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
7.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
8.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
9.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
10.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
11.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2019-2024)
Table 4. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2025-2030)
Table 6. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2024)
Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2024)
Table 24. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Drugs for Herpes Labialis (Oral Herpes) Industry Trends
Table 37. Drugs for Herpes Labialis (Oral Herpes) Industry Drivers
Table 38. Drugs for Herpes Labialis (Oral Herpes) Industry Opportunities and Challenges
Table 39. Drugs for Herpes Labialis (Oral Herpes) Industry Restraints
Table 40. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2019-2024)
Table 42. Global Drugs for Herpes Labialis (Oral Herpes) Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Drugs for Herpes Labialis (Oral Herpes) Key Company Headquarters & Area Served
Table 44. Global Drugs for Herpes Labialis (Oral Herpes) Company, Product Type & Application
Table 45. Global Drugs for Herpes Labialis (Oral Herpes) Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Drugs for Herpes Labialis (Oral Herpes) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. GSK Business Overview
Table 49. GSK Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. GSK Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 51. GSK Recent Development
Table 52. Novartis Company Information
Table 53. Novartis Business Overview
Table 54. Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Novartis Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 56. Novartis Recent Development
Table 57. Teva Company Information
Table 58. Teva Business Overview
Table 59. Teva Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Teva Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 61. Teva Recent Development
Table 62. Mylan Company Information
Table 63. Mylan Business Overview
Table 64. Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Mylan Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 66. Mylan Recent Development
Table 67. Cadila Company Information
Table 68. Cadila Business Overview
Table 69. Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Cadila Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 71. Cadila Recent Development
Table 72. Apotex Company Information
Table 73. Apotex Business Overview
Table 74. Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Apotex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 76. Apotex Recent Development
Table 77. Daewoong Pharmaceutical Company Information
Table 78. Daewoong Pharmaceutical Business Overview
Table 79. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 81. Daewoong Pharmaceutical Recent Development
Table 82. Livzon Company Information
Table 83. Livzon Business Overview
Table 84. Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Livzon Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 86. Livzon Recent Development
Table 87. Luoxin Company Information
Table 88. Luoxin Business Overview
Table 89. Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 91. Luoxin Recent Development
Table 92. Med shine Company Information
Table 93. Med shine Business Overview
Table 94. Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Med shine Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 96. Med shine Recent Development
Table 97. Bayer (Campho Phenique) Company Information
Table 98. Bayer (Campho Phenique) Business Overview
Table 99. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 101. Bayer (Campho Phenique) Recent Development
Table 102. Blistex Company Information
Table 103. Blistex Business Overview
Table 104. Blistex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Blistex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 106. Blistex Recent Development
Table 107. Kelun Company Information
Table 108. Kelun Business Overview
Table 109. Kelun Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. Kelun Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 111. Kelun Recent Development
Table 112. Hikma Company Information
Table 113. Hikma Business Overview
Table 114. Hikma Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. Hikma Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 116. Hikma Recent Development
Table 117. Haiwang Company Information
Table 118. Haiwang Business Overview
Table 119. Haiwang Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 121. Haiwang Recent Development
Table 122. Carmex Company Information
Table 123. Carmex Business Overview
Table 124. Carmex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 125. Carmex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 126. Carmex Recent Development
Table 127. Cipher Company Information
Table 128. Cipher Business Overview
Table 129. Cipher Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 130. Cipher Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 131. Cipher Recent Development
Table 132. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 133. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 134. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 135. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 136. North America Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 137. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 138. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 139. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 140. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 141. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 142. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 143. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 144. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 145. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 146. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 147. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 148. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 149. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 150. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 151. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 152. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 154. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 155. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 157. Research Programs/Design for This Report
Table 158. Authors List of This Report
Table 159. Secondary Sources
Table 160. Primary Sources
Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2019-2024)
Table 4. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2025-2030)
Table 6. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2024)
Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2024)
Table 24. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Drugs for Herpes Labialis (Oral Herpes) Industry Trends
Table 37. Drugs for Herpes Labialis (Oral Herpes) Industry Drivers
Table 38. Drugs for Herpes Labialis (Oral Herpes) Industry Opportunities and Challenges
Table 39. Drugs for Herpes Labialis (Oral Herpes) Industry Restraints
Table 40. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2019-2024)
Table 42. Global Drugs for Herpes Labialis (Oral Herpes) Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Drugs for Herpes Labialis (Oral Herpes) Key Company Headquarters & Area Served
Table 44. Global Drugs for Herpes Labialis (Oral Herpes) Company, Product Type & Application
Table 45. Global Drugs for Herpes Labialis (Oral Herpes) Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Drugs for Herpes Labialis (Oral Herpes) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. GSK Business Overview
Table 49. GSK Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. GSK Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 51. GSK Recent Development
Table 52. Novartis Company Information
Table 53. Novartis Business Overview
Table 54. Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Novartis Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 56. Novartis Recent Development
Table 57. Teva Company Information
Table 58. Teva Business Overview
Table 59. Teva Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Teva Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 61. Teva Recent Development
Table 62. Mylan Company Information
Table 63. Mylan Business Overview
Table 64. Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Mylan Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 66. Mylan Recent Development
Table 67. Cadila Company Information
Table 68. Cadila Business Overview
Table 69. Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Cadila Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 71. Cadila Recent Development
Table 72. Apotex Company Information
Table 73. Apotex Business Overview
Table 74. Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Apotex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 76. Apotex Recent Development
Table 77. Daewoong Pharmaceutical Company Information
Table 78. Daewoong Pharmaceutical Business Overview
Table 79. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 81. Daewoong Pharmaceutical Recent Development
Table 82. Livzon Company Information
Table 83. Livzon Business Overview
Table 84. Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Livzon Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 86. Livzon Recent Development
Table 87. Luoxin Company Information
Table 88. Luoxin Business Overview
Table 89. Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 91. Luoxin Recent Development
Table 92. Med shine Company Information
Table 93. Med shine Business Overview
Table 94. Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Med shine Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 96. Med shine Recent Development
Table 97. Bayer (Campho Phenique) Company Information
Table 98. Bayer (Campho Phenique) Business Overview
Table 99. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 101. Bayer (Campho Phenique) Recent Development
Table 102. Blistex Company Information
Table 103. Blistex Business Overview
Table 104. Blistex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Blistex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 106. Blistex Recent Development
Table 107. Kelun Company Information
Table 108. Kelun Business Overview
Table 109. Kelun Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. Kelun Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 111. Kelun Recent Development
Table 112. Hikma Company Information
Table 113. Hikma Business Overview
Table 114. Hikma Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 115. Hikma Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 116. Hikma Recent Development
Table 117. Haiwang Company Information
Table 118. Haiwang Business Overview
Table 119. Haiwang Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 120. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 121. Haiwang Recent Development
Table 122. Carmex Company Information
Table 123. Carmex Business Overview
Table 124. Carmex Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 125. Carmex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 126. Carmex Recent Development
Table 127. Cipher Company Information
Table 128. Cipher Business Overview
Table 129. Cipher Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 130. Cipher Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
Table 131. Cipher Recent Development
Table 132. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 133. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 134. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 135. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 136. North America Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 137. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 138. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 139. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 140. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 141. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 142. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 143. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 144. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 145. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 146. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 147. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 148. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 149. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 150. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 151. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 152. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024) & (US$ Million)
Table 154. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2024)
Table 155. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Country (2025-2030)
Table 157. Research Programs/Design for This Report
Table 158. Authors List of This Report
Table 159. Secondary Sources
Table 160. Primary Sources
LIST OF FIGURES
Figure 1. Drugs for Herpes Labialis (Oral Herpes) Product Picture
Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030) & (US$ Million)
Figure 4. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region: 2023 VS 2030
Figure 5. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2019-2030)
Figure 6. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Aciclovir
Figure 12. Global Aciclovir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Valacyclovir
Figure 14. Global Valacyclovir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Famciclovir
Figure 16. Global Famciclovir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Docosanol
Figure 18. Global Docosanol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Other
Figure 20. Global Other Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 22. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type 2023 VS 2030
Figure 23. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 24. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 25. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 26. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 27. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 28. Product Picture of External Use
Figure 29. Global External Use Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Oral
Figure 31. Global Oral Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Product Picture of Injection
Figure 33. Global Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 35. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application 2023 VS 2030
Figure 36. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 37. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 38. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 39. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 40. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 41. Global Top 5 and 10 Drugs for Herpes Labialis (Oral Herpes) Players Market Share by Revenue in 2023
Figure 42. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 43. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 46. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 47. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 48. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 49. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 52. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 53. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 54. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 56. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 58. Years Considered
Figure 59. Research Process
Figure 60. Key Executives Interviewed
Figure 1. Drugs for Herpes Labialis (Oral Herpes) Product Picture
Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030) & (US$ Million)
Figure 4. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region: 2023 VS 2030
Figure 5. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2019-2030)
Figure 6. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Aciclovir
Figure 12. Global Aciclovir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Valacyclovir
Figure 14. Global Valacyclovir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Famciclovir
Figure 16. Global Famciclovir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Docosanol
Figure 18. Global Docosanol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Other
Figure 20. Global Other Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 22. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type 2023 VS 2030
Figure 23. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 24. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 25. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 26. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 27. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Type (2019-2030)
Figure 28. Product Picture of External Use
Figure 29. Global External Use Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Oral
Figure 31. Global Oral Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Product Picture of Injection
Figure 33. Global Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 35. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application 2023 VS 2030
Figure 36. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 37. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 38. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 39. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 40. Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Share by Application (2019-2030)
Figure 41. Global Top 5 and 10 Drugs for Herpes Labialis (Oral Herpes) Players Market Share by Revenue in 2023
Figure 42. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 43. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 46. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 47. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 48. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 49. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 52. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 53. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 54. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 56. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2019-2030)
Figure 58. Years Considered
Figure 59. Research Process
Figure 60. Key Executives Interviewed
